Noga, Heather

Supplementary Material 1

Supplementary Material 1

Abstract Background We recognized a paucity of accessible, evidence-based, empowering patient-centred resources for those with endometriosis-associated dyspareunia. Affecting more than 50% of people with endometriosis, dyspareunia can signi…

Abstract Background We recognized a paucity of accessible, evidence-based, empowering patient-centred resources for those with endometriosis-associated dyspareunia. Affecting more than 50% of people with endometriosis, dyspareunia can signi…

Endometriosis is a gynecological disorder associated with local inflammation and neuroproliferation. Increased nerve bundle density has been attributed to increased expression of nerve growth factor (NGF) and interleukin–1β (IL-1β). Immunoh…

A key clinical problem is identifying the endometriosis patient whose pain is complicated by central nervous system sensitization, where conventional gynecologic treatment (e.g. hormonal therapy or surgery) may not completely alleviate the …

Background: Endometriosis is a complex condition that can negatively affect a woman’s quality of life, including her sleep. This study aims to assess the multifactorial variables associated with poorer quality of sleep in women with endomet…

Background. Deep dyspareunia, a common symptom in endometriosis, has previously been associated with bladder or pelvic floor tenderness (BPFT), which suggests a role for central nervous system sensitization. The Central Sensitization Invent…

Background. The etiology of endometriosis-associated deep dyspareunia may include direct endometriosis-specific factors (e.g., Stage or invasiveness of disease) and/or indirect contributors such as bladder/pelvic floor dysfunction (e.g., re…

Background: Endometriosis is a gynaecological disease that affects 1 in 10 women in Canada and is characterized by the presence of endometrial cells outside the uterus leading to painful periods, chronic pelvic pain, and sexual pain. Painfu…